Full article: Intranasal and Intramuscular Immunization with Outer Membrane Vesicles from Serogroup C Meningococci Induced Functional Antibodies and Immunologic Memory

Membrane particles evoke a serotype-independent cross-protection against pneumococcal infection that is dependent on the conserved lipoproteins MalX and PrsA

Vaccines, Free Full-Text

An intranasal OMV-based vaccine induces high mucosal and systemic protecting immunity against a SARS-CoV-2 infection

Serogroup B meningococcal vaccines—an unfinished story - The Lancet Infectious Diseases

Intranasal immunization with outer membrane vesicles (OMV) protects against airway colonization and systemic infection with Acinetobacter baumannii - Journal of Infection

Nanostrategies to Develop Current Antiviral Vaccines

Meningococcal Disease

Outer membrane vesicles as platform vaccine technology - van der Pol - 2015 - Biotechnology Journal - Wiley Online Library

Frontiers Protection Against Invasive Infections in Children Caused by Encapsulated Bacteria

Recombinant Neisseria surface protein A is a potential vaccine candidate against Neisseria meningitides serogroup B